LIMK1 and schizophrenia: For example, through pharmacological inhibition of LIMK1 using Pyr1, it was shown that the synaptic and behavioural deficits, including reduced spine density, impaired LTP, social withdrawal and anxiety-like behaviour in MAP6 KO mice (an animal model of schizophrenia), were rescued [208].